Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Ramiro Garzon (Inventor), Adrienne Dorrance (Inventor), Dimitrios Papaioannou (Inventor), Robert Lee (Inventor), Sakari Kauppinen (Inventor), Andreas Petri (Inventor), Charlotte Albæk Thrue (Inventor)

Research output: PatentResearch

Abstract

The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

Original languageEnglish
IPCC12N 15/ 113 A I
Patent numberWO2018085656
Filing date11/05/2018
CountryDenmark
Priority date03/11/2016
Priority numberUS201662416993P
Publication statusPublished - 2018

Fingerprint

Long Noncoding RNA
Untranslated RNA
Disclosure
Acute Myeloid Leukemia

Cite this

Garzon, R., Dorrance, A., Papaioannou, D., Lee, R., Kauppinen, S., Petri, A., & Albæk Thrue, C. (2018). IPC No. C12N 15/ 113 A I. Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. (Patent No. WO2018085656).
Garzon, Ramiro (Inventor) ; Dorrance, Adrienne (Inventor) ; Papaioannou, Dimitrios (Inventor) ; Lee, Robert (Inventor) ; Kauppinen, Sakari (Inventor) ; Petri, Andreas (Inventor) ; Albæk Thrue, Charlotte (Inventor). / Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. IPC No.: C12N 15/ 113 A I. Patent No.: WO2018085656. May 11, 2018.
@misc{cce5ad290e5b4078ad8df938d95ac688,
title = "Antisense oligomers targeting HOXB-AS3 lon non-coding RNA",
abstract = "The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.",
author = "Ramiro Garzon and Adrienne Dorrance and Dimitrios Papaioannou and Robert Lee and Sakari Kauppinen and Andreas Petri and {Alb{\ae}k Thrue}, Charlotte",
year = "2018",
language = "English",
type = "Patent",
note = "WO2018085656; C12N 15/ 113 A I",

}

Garzon, R, Dorrance, A, Papaioannou, D, Lee, R, Kauppinen, S, Petri, A & Albæk Thrue, C May. 11 2018, Antisense oligomers targeting HOXB-AS3 lon non-coding RNA, Patent No. WO2018085656, IPC No. C12N 15/ 113 A I.

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. / Garzon, Ramiro (Inventor); Dorrance, Adrienne (Inventor); Papaioannou, Dimitrios (Inventor); Lee, Robert (Inventor); Kauppinen, Sakari (Inventor); Petri, Andreas (Inventor); Albæk Thrue, Charlotte (Inventor).

IPC No.: C12N 15/ 113 A I. Patent No.: WO2018085656. May 11, 2018.

Research output: PatentResearch

TY - PAT

T1 - Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

AU - Garzon, Ramiro

AU - Dorrance, Adrienne

AU - Papaioannou, Dimitrios

AU - Lee, Robert

AU - Kauppinen, Sakari

AU - Petri, Andreas

AU - Albæk Thrue, Charlotte

PY - 2018

Y1 - 2018

N2 - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

AB - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

M3 - Patent

M1 - WO2018085656

Y2 - 2018/05/11

ER -

Garzon R, Dorrance A, Papaioannou D, Lee R, Kauppinen S, Petri A et al, inventors. Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. C12N 15/ 113 A I. 2018.